Vitamin B12 in drug delivery: Breaking through the barriers to a B12 bioconjugate pharmaceutical

Susan M. Clardy, Damian G. Allis, Timothy J. Fairchild, Robert Patrick Doyle

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Importance of the field: Vitamin B12 (B12) is a rare and vital micronutrient for which mammals have developed a complex and highly efficient dietary uptake system. This uptake pathway consists of a series of proteins and receptors, and has been utilized to deliver several bioactive and/or imaging molecules from 99mTc to insulin. Areas covered in this review: The current field of B12-based drug delivery is reviewed, including recent highlights surrounding the very pathway itself. What the reader will gain: Despite over 30 years of work, no B12-based drug delivery conjugate has reached the market-place, hampered by issues such as limited uptake capacity, gastrointestinal degradation of the conjugate or high background uptake by healthy tissues. Variability in dose response among individuals, especially across ageing populations and slow oral uptake (several hours), has also slowed development and interest. Take home message: This review is intended to stress again the great potential, as yet not fully realized, for B 12-based therapeutics, tumor imaging and oral drug delivery. This review discusses recent reports that demonstrate that the issues noted above can be overcome and need not be seen as negating the great potential of B 12 in the drug delivery field.

Original languageEnglish (US)
Pages (from-to)127-140
Number of pages14
JournalExpert Opinion on Drug Delivery
Volume8
Issue number1
DOIs
StatePublished - Jan 2011

Fingerprint

Vitamin B 12
Pharmaceutical Preparations
Micronutrients
Mammals
Insulin
Population
Neoplasms
Proteins
Therapeutics

Keywords

  • B
  • Cobalamin
  • Haptocorrin
  • Intrinsic factor
  • Peptides
  • Transcobalamin

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Vitamin B12 in drug delivery : Breaking through the barriers to a B12 bioconjugate pharmaceutical. / Clardy, Susan M.; Allis, Damian G.; Fairchild, Timothy J.; Doyle, Robert Patrick.

In: Expert Opinion on Drug Delivery, Vol. 8, No. 1, 01.2011, p. 127-140.

Research output: Contribution to journalArticle

Clardy, Susan M. ; Allis, Damian G. ; Fairchild, Timothy J. ; Doyle, Robert Patrick. / Vitamin B12 in drug delivery : Breaking through the barriers to a B12 bioconjugate pharmaceutical. In: Expert Opinion on Drug Delivery. 2011 ; Vol. 8, No. 1. pp. 127-140.
@article{1fed20c610004cdeb03f77bf7bffcc56,
title = "Vitamin B12 in drug delivery: Breaking through the barriers to a B12 bioconjugate pharmaceutical",
abstract = "Importance of the field: Vitamin B12 (B12) is a rare and vital micronutrient for which mammals have developed a complex and highly efficient dietary uptake system. This uptake pathway consists of a series of proteins and receptors, and has been utilized to deliver several bioactive and/or imaging molecules from 99mTc to insulin. Areas covered in this review: The current field of B12-based drug delivery is reviewed, including recent highlights surrounding the very pathway itself. What the reader will gain: Despite over 30 years of work, no B12-based drug delivery conjugate has reached the market-place, hampered by issues such as limited uptake capacity, gastrointestinal degradation of the conjugate or high background uptake by healthy tissues. Variability in dose response among individuals, especially across ageing populations and slow oral uptake (several hours), has also slowed development and interest. Take home message: This review is intended to stress again the great potential, as yet not fully realized, for B 12-based therapeutics, tumor imaging and oral drug delivery. This review discusses recent reports that demonstrate that the issues noted above can be overcome and need not be seen as negating the great potential of B 12 in the drug delivery field.",
keywords = "B, Cobalamin, Haptocorrin, Intrinsic factor, Peptides, Transcobalamin",
author = "Clardy, {Susan M.} and Allis, {Damian G.} and Fairchild, {Timothy J.} and Doyle, {Robert Patrick}",
year = "2011",
month = "1",
doi = "10.1517/17425247.2011.539200",
language = "English (US)",
volume = "8",
pages = "127--140",
journal = "Expert Opinion on Drug Delivery",
issn = "1742-5247",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Vitamin B12 in drug delivery

T2 - Breaking through the barriers to a B12 bioconjugate pharmaceutical

AU - Clardy, Susan M.

AU - Allis, Damian G.

AU - Fairchild, Timothy J.

AU - Doyle, Robert Patrick

PY - 2011/1

Y1 - 2011/1

N2 - Importance of the field: Vitamin B12 (B12) is a rare and vital micronutrient for which mammals have developed a complex and highly efficient dietary uptake system. This uptake pathway consists of a series of proteins and receptors, and has been utilized to deliver several bioactive and/or imaging molecules from 99mTc to insulin. Areas covered in this review: The current field of B12-based drug delivery is reviewed, including recent highlights surrounding the very pathway itself. What the reader will gain: Despite over 30 years of work, no B12-based drug delivery conjugate has reached the market-place, hampered by issues such as limited uptake capacity, gastrointestinal degradation of the conjugate or high background uptake by healthy tissues. Variability in dose response among individuals, especially across ageing populations and slow oral uptake (several hours), has also slowed development and interest. Take home message: This review is intended to stress again the great potential, as yet not fully realized, for B 12-based therapeutics, tumor imaging and oral drug delivery. This review discusses recent reports that demonstrate that the issues noted above can be overcome and need not be seen as negating the great potential of B 12 in the drug delivery field.

AB - Importance of the field: Vitamin B12 (B12) is a rare and vital micronutrient for which mammals have developed a complex and highly efficient dietary uptake system. This uptake pathway consists of a series of proteins and receptors, and has been utilized to deliver several bioactive and/or imaging molecules from 99mTc to insulin. Areas covered in this review: The current field of B12-based drug delivery is reviewed, including recent highlights surrounding the very pathway itself. What the reader will gain: Despite over 30 years of work, no B12-based drug delivery conjugate has reached the market-place, hampered by issues such as limited uptake capacity, gastrointestinal degradation of the conjugate or high background uptake by healthy tissues. Variability in dose response among individuals, especially across ageing populations and slow oral uptake (several hours), has also slowed development and interest. Take home message: This review is intended to stress again the great potential, as yet not fully realized, for B 12-based therapeutics, tumor imaging and oral drug delivery. This review discusses recent reports that demonstrate that the issues noted above can be overcome and need not be seen as negating the great potential of B 12 in the drug delivery field.

KW - B

KW - Cobalamin

KW - Haptocorrin

KW - Intrinsic factor

KW - Peptides

KW - Transcobalamin

UR - http://www.scopus.com/inward/record.url?scp=78650557242&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650557242&partnerID=8YFLogxK

U2 - 10.1517/17425247.2011.539200

DO - 10.1517/17425247.2011.539200

M3 - Article

C2 - 21128823

AN - SCOPUS:78650557242

VL - 8

SP - 127

EP - 140

JO - Expert Opinion on Drug Delivery

JF - Expert Opinion on Drug Delivery

SN - 1742-5247

IS - 1

ER -